TrialCPT: pharmacometrics & systems pharmacology2023

Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.